Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Lung Neoplasms and CDK4[original query] |
|---|
| Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
| Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep 11 (9): 1493-502. Schrock Alexa B, Frampton Garrett M, Suh James, Chalmers Zachary R, Rosenzweig Mark, Erlich Rachel L, Halmos Balazs, Goldman Jonathan, Forde Patrick, Leuenberger Kurt, Peled Nir, Kalemkerian Gregory P, Ross Jeffrey S, Stephens Philip J, Miller Vincent A, Ali Siraj M, Ou Sai-Hong Ignati |
| Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors. Translational oncology 2019 Aug 12 (11): 1425-1431. Chang Shih-Chieh, Lai Yi-Chun, Chang Cheng-Yu, Huang Li-Kuo, Chen Shu-Jen, Tan Kien Thiam, Yu Pei-Ning, Lai Jiun |
| Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases. JAMA network open 2020 Aug 3 (8): e209077. Li Yang-Si, Zheng Mei-Mei, Jiang Ben-Yuan, Tu Hai-Yan, Yang Jin-Ji, Zhang Xu-Chao, Wu Yi-Lo |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 10 16 (2): 250-258. Zheng Mei-Mei, Li Yang-Si, Tu Hai-Yan, Jiang Ben-Yuan, Yang Jin-Ji, Zhou Qing, Xu Chong-Rui, Yang Xiao-Rong, Wu Yi-Lo |
| Mutational characteristics of bone metastasis of lung cancer. Annals of palliative medicine 2021 9 10 (8): 8818-8826. Huang Xin, Shi Xiaoliang, Huang Donghua, Li Binghao, Lin Nong, Pan Weibo, Yan Xiaobo, Li Hengyuan, Hao Qing, Ye Zhaomi |
| Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 12 112 (5): 1165-1176. Li Li, Tang Shanshan, Yin Jiani C, Dong Lihua, Yang Zhe, Liu Yueping, Ma Jie, Chang Pengyu, Pang Jiaohui, Bao Hua, Mu Dianbin, Zheng Xiaoli, Aishajiang Reyida, He Kewen, Zhang Shaotong, Ni Meng, Wu Xue, Wang Xiaonan, Shao Yang, Wang Jun, Ge Hong, Yu Jinming, Yuan Shuang |
| A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance. Frontiers in oncology 2021 10 11 722039. Liu Li, Qu Jingjing, Heng Jianfu, Zhou Chunhua, Xiong Yi, Yang Haiyan, Jiang Wenjuan, Zeng Liang, Zhu Songlin, Zhang Yongchang, Tan Jiarong, Hu Chengping, Deng Pengbo, Yang No |
| Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma. Cell death & disease 2021 10 12 (10): 935. Deng Zhiyong, Cui Liang, Li Pansong, Ren Nianjun, Zhong Zhe, Tang Zhi, Wang Lei, Gong Jianwu, Cheng Haofeng, Guan Yanfang, Yi Xin, Xia Xuefeng, Zhou Rongrong, He Zhengw |
| Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib. Journal of Cancer 2021 1 12 (3): 644-651. Cheng Tianli, Gu Zhongping, Song Danni, Liu Sisi, Tong Xiaoling, Wu Xue, Lin Zhifeng, Hong W |
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
| Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII 2022 11 . Chen Cunte, Liu Siyang Maggie, Chen Yedan, Ou Qiuxiang, Bao Hua, Xu Ling, Zhang Yikai, Zhang Jia-Tao, Zhong Wenzhao, Zhou Qing, Yang Xue-Ning, Shao Yang, Wu Yi-Long, Liu Si-Yang, Li Yangq |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution. Heliyon 2023 1 8 (12): e12374. Yang Hainan, Wen Lei, Zhao Chao, Chen Jianing, Zhou Zhaoming, Zhou Cheng, Cai Linbo, Zhou Caic |
| Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
| Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 5 . Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Ho |
- Page last reviewed:Feb 1, 2024
- Content source: